According to Zacks, “OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. “
A number of other brokerages have also commented on KIDS. ValuEngine lowered shares of Orthopediatrics from a buy rating to a hold rating in a research note on Thursday, August 1st. Piper Jaffray Companies boosted their price target on shares of Orthopediatrics from $40.00 to $44.00 and gave the company an overweight rating in a research note on Friday. Finally, BidaskClub lowered shares of Orthopediatrics from a buy rating to a hold rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has a consensus rating of Buy and an average price target of $44.40.
Orthopediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.18) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.01). The business had revenue of $20.74 million for the quarter, compared to the consensus estimate of $19.87 million. Orthopediatrics had a negative net margin of 15.77% and a negative return on equity of 12.92%. The business’s revenue for the quarter was up 31.1% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.15) EPS. Equities analysts forecast that Orthopediatrics will post -0.82 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of KIDS. Roubaix Capital LLC bought a new stake in shares of Orthopediatrics in the 2nd quarter worth $3,497,000. Aperio Group LLC bought a new stake in shares of Orthopediatrics in the 2nd quarter worth $39,000. Swiss National Bank bought a new stake in shares of Orthopediatrics in the 2nd quarter worth $640,000. Conestoga Capital Advisors LLC grew its stake in shares of Orthopediatrics by 4.4% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 10,395 shares of the company’s stock worth $405,000 after acquiring an additional 440 shares in the last quarter. Finally, Wells Fargo & Company MN grew its stake in shares of Orthopediatrics by 7.2% in the 2nd quarter. Wells Fargo & Company MN now owns 199,364 shares of the company’s stock worth $7,775,000 after acquiring an additional 13,427 shares in the last quarter. Hedge funds and other institutional investors own 49.01% of the company’s stock.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Further Reading: Average Daily Trade Volume – ADTV
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.